All information about headache research, headache diagnostics and headache therapy
43.5 billion annually in direct and indirect costs The high direct and indirect costs mean that, after senile dementia and stroke, migraines and other headache diseases are among the three most expensive neurological diseases with the highest [...]
Cluster headaches get their name because they occur frequently in specific periods of time, in so-called clusters. The time span of the cluster periods can be several weeks, several months or years. [...]
There are only a few effective treatment options for particularly severely affected patients with chronic migraines and other severe chronic pain. Standard therapy procedures are usually without lasting effectiveness. In the latest [...]
In 2006, the US Food and Drug Administration (FDA) issued a warning regarding a possible life-threatening risk of serotonin syndrome when triptans are used in combination with a selective serotonin reuptake inhibitor (SSRI) or a selective serotonin/norepinephrine reuptake inhibitor ( SNRI) uses [...]
The regional pain center in Essen under the direction of Dr. Astrid Gendolla in Essen organized the traditional Essen Pain Talks from November 23rd to 24th, 2012 in Essen. This year's event was held under the anniversary motto "15 years of cooperation between Kiel - [...]
Migraines Affect Children's Academic Performance: Headaches are the most common and serious health problem among schoolchildren. This has already been demonstrated by previous data from schools in Schleswig-Holstein. Children with migraines more frequently show difficulties [...]
Why skipping breakfast creates cravings for high-calorie foods: Fasting ultimately leads to an excessive intake of energy needs, especially in the evening. Fasting activates addictive and reward behaviors in the brain for high-calorie foods [...]
The question of whether botulinum toxin can also be used in cases of existing medication overuse headache (MOH) is causing confusion. The background and our conclusions from the Kiel Pain Clinic for practical application will therefore be explained below. [...]
Occipital nerve stimulation for the treatment of chronic migraine. Chronic migraine is a particularly severe form of migraine. Affected patients suffer from severe headaches on more than 15 days per month. The high frequency of headache days [...]
According to a recent decision by the Federal Joint Committee (G-BA), the calcium antagonist verapamil will in future be prescribable under statutory health insurance for the indication of cluster headache, even beyond its current approved indication. The Federal Joint Committee has [...]
The Cluster Headache Competence Center at the Kiel Pain Clinic and the Federal Association of Cluster Headache Self-Help Groups (CSG) eV held events on August 10th and 11th, 2012 at the Kiel Pain Clinic, Heikendorfer Weg 9-27, 24149 Kiel, as part of the 3rd .Kieler [...]
A global collaboration of scientists, including a research team from the Kiel Pain Clinic, has identified four new gene loci whose alterations significantly increase the risk of migraines. These recent discoveries provide important new insights [...]
The standard work on headaches, migraines, and neuralgia. Headaches are the number one health problem. Over 250 different primary diagnoses are currently distinguished. This work comprehensively and uniquely on the German market describes the classification and diagnosis of all [...]
Acetylsalicylic acid should not be taken during the first and second trimesters of pregnancy unless medically necessary. This is due to the increased risk of miscarriage and birth defects. New studies now show that even [...]
Approximately 10-15% of all Europeans suffer from migraines. Recent research suggests, among other things, a link between migraines and a common heart defect, a patent foramen ovale (PFO, "oval hole"). A PFO is a small opening between [...]
When the International Headache Society published the first edition of the International Classification of Headache Disorders (ICHD-I) in 1988, chronic migraine was not among the 165 listed diagnoses. Migraine [...]
The drug Botox® (botulinum toxin type A) was approved on September 23, 2011, for the relief of symptoms of chronic migraine in adults who have not responded adequately to prophylactic migraine treatments or [...]
Merck halts clinical development program for CGRP antagonist telcagepant. A new therapeutic mechanism for migraine treatment was developed for clinical application with the CGRP antagonists MK-0974 and MK-3207. These are two drugs currently undergoing clinical research programs [...]
Professor Dr. Hartmut Göbel and the team at the Kiel Pain Clinic have developed a new interactive online headache calendar for you. It is designed to help migraine and headache patients to specifically monitor the course of their headache condition [...]
Those suffering from migraines, headaches, back pain, and other chronic pain are particularly interested in knowing where to find targeted help locally. Prof. [...] has developed a new guide to a modern healthcare landscape
